Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 1861-1868
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1861
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1861
Table 2 Univariate and multivariate analysis of clinicopathologic characteristics on survival
Clinicopathologic characteristics | Univariate analyses, HR (95%CI) | P value | Multivariate analyses, HR (95%CI) | P value |
Age in yr, < 65 vs ≥ 65 | 1.366 (0.942-1.979) | 0.100 | N/A | N/A |
Sex, female vs male | 0.963 (0.776-1.196) | 0.735 | N/A | N/A |
PS score in points, 0 or 1 vs 2 or 3 | 1.142 (0.745-1.753) | 0.542 | N/A | N/A |
Differentiation, moderate or well vs poor | 0.947 (0.622-1.441) | 0.800 | N/A | N/A |
Number of metastases, < 2 vs ≥ 2 | 1.416 (0.947-2.118) | 0.090 | N/A | N/A |
CEA level, < 5 vs ≥ 5 | 1.707 (1.144-2.548) | 0.009 | 1.650 (1.102-2.469) | 0.015 |
Smoking history, yes vs no | 0.956 (0.794-1.151) | 0.634 | N/A | N/A |
Presence of sarcopenia, yes vs no | 9.512 (5.489-16.484) | 0.000 | 9.542 (5.398-16.867) | 0.000 |
BMI in kg/m2: underweight, < 18.5; normal, 18.5-24.9; overweight, 25.0-29.9; obese, > 30.0 | 0.914 (0.722-1.157) | 0.456 | N/A | N/A |
- Citation: Dogan O, Sahinli H, Duzkopru Y, Akdag T, Kocanoglu A. Is sarcopenia effective on survival in patients with metastatic gastric cancer? World J Gastrointest Oncol 2024; 16(5): 1861-1868
- URL: https://www.wjgnet.com/1948-5204/full/v16/i5/1861.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.1861